Rare diseases
Investigational molecules
Locations
Back to Germany1 444 clinical trials in Hochheim Am Main, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Safety and Effectiveness of Bemnifosbuvir and Ruzasvir for Patients with Chronic Hepatitis C
GermanyStudy of DKN-01 and Tislelizumab with Chemotherapy for Adults with Advanced Gastric or Gastroesophageal Cancer
GermanyStudy on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
GermanyStudy on Volixibat for Treating Itching in Patients with Primary Biliary Cholangitis
GermanyStudy of Durvalumab and Tremelimumab for Patients with Advanced Liver Cancer
GermanyStudy on the Safety and Effectiveness of SerpinPC for Patients with Hemophilia B with Inhibitors
GermanyStudy on Rifaximin for Delaying Hepatic Encephalopathy in Cirrhosis Patients
GermanyStudy on the Effects and Safety of SAR442970 for Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyStudy on the Effectiveness and Safety of Ruxolitinib Cream for Patients with Prurigo Nodularis
GermanyStudy of RO7247669 and Nab-Paclitaxel vs. Pembrolizumab and Nab-Paclitaxel for Patients with Untreated, PD-L1 Positive, Advanced Triple-Negative Breast Cancer
GermanyStudy on Long-Term Safety of Ligelizumab for Patients with Food Allergies
GermanyStudy on the Effectiveness and Safety of Glofitamab with Drug Combination for Untreated Large B-Cell Lymphoma Patients
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Gaucher disease and Niemann-Pick disease, exploring new therapeutic approaches for these challenging genetic conditions. Studies aim to evaluate novel treatments for improving neurological symptoms and overall patient outcomes.
Clinical investigations evaluating venglustat and nizubaglustat's effectiveness in managing disease progression.
Research centered on treating Mucopolysaccharidosis Type II (Hunter Syndrome) and Pompe disease, with multiple studies investigating innovative enzyme replacement therapies and novel drug combinations.
Evaluation of treatments like JR-141 and cipaglucosidase alfa for improved patient outcomes.
Studies focused on preventing respiratory syncytial virus infections in older adults, with particular attention to vaccine development and immune response assessment.
Investigation of revaccination strategies and long-term protection against respiratory infections.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
